Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Cyterix Pharmaceuticals is a cancer therapeutics company developing small molecule prodrugs.
Imagen Biotech is focused on identifying and developing therapeutics for blinding diseases.
Convergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.
SV Health Investors has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
SV Health Investors's top investment sectors include Biotechnology, Therapeutics, Health Care, Biopharma, Pharmaceutical. The firm invests across 7 different industry categories.
Among tracked funding rounds, Imagen Biotech received $40.0M in a Series A round. SV Health Investors's total known invested capital is $1.9B.
SV Health Investors's average investment size is $34.1M across its portfolio of 76 companies.